Here's Why Dentsply International (XRAY) is a Strong Value Stock

Dentsply Sirona (XRAY) has been highlighted as a strong value stock, earning a Zacks Rank #2 (Buy) and top-tier 'A' ratings for both its Value and overall VGM Style Scores. This favorable outlook is supported by an attractive forward P/E ratio of 8.24 and recent upward revisions to its fiscal 2025 earnings estimates, with the Zacks Consensus Estimate increasing to $1.90 per share. The company also demonstrates a consistent positive earnings surprise history, averaging +2.7%, positioning XRAY as a compelling consideration for investors.

Analysis

Dentsply Sirona (XRAY) is presented as a compelling value investment, supported by a Zacks Rank of #2 (Buy) and top-tier 'A' ratings for both its overall VGM and specific Value Style Scores. The company's valuation is highlighted as attractive, evidenced by a forward Price-to-Earnings (P/E) ratio of 8.24. This positive outlook is reinforced by recent analyst activity, where two analysts have revised fiscal 2025 earnings estimates upwards in the last 60 days, nudging the Zacks Consensus Estimate to $1.90 per share. Furthermore, the company has a track record of operational outperformance, demonstrating an average positive earnings surprise of 2.7%, which suggests a consistent ability to exceed market expectations.

Key Decisions for Investors

• Given the 'A' score for Value and a forward P/E of 8.24, value-oriented investors should consider this an attractive entry point for a global leader in the dental products sector.
• The upward revisions to fiscal 2025 earnings estimates, though modest, signal positive analyst sentiment, making it prudent to monitor for continued improvements in consensus forecasts.
• The combination of a #2 (Buy) rank, strong quantitative scores, and a history of positive earnings surprises supports a bullish view, warranting further due diligence on the stock's fundamentals and competitive positioning.